[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

Barber et al., 2023 - Google Patents

Metabolic response of intestinal microbiota to guar gum consumption

Barber et al., 2023

View HTML
Document ID
7773494703313816745
Author
Barber C
Sabater C
Guarner F
Margolles A
Azpiroz F
Publication year
Publication venue
Frontiers in Nutrition

External Links

Snippet

Background Guar gum is used extensively as a thickening agent in food, but it remains uncertain whether and to what extent it is fermented by colonic microbiota and whether it has microbiota modulatory properties. Aim To determine the metabolic response of intestinal …
Continue reading at www.frontiersin.org (HTML) (other versions)

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Micro-organisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/745—Bifidobacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Micro-organisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters

Similar Documents

Publication Publication Date Title
Tandon et al. A prospective randomized, double-blind, placebo-controlled, dose-response relationship study to investigate efficacy of f ructo-o ligo s accharides (FOS) on human gut microflora
McBurney et al. Establishing what constitutes a healthy human gut microbiome: state of the science, regulatory considerations, and future directions
Birkeland et al. Prebiotic effect of inulin-type fructans on faecal microbiota and short-chain fatty acids in type 2 diabetes: a randomised controlled trial
Reimer et al. Effect of chicory inulin-type fructan–containing snack bars on the human gut microbiota in low dietary fiber consumers in a randomized crossover trial
Garcia-Mantrana et al. Shifts on gut microbiota associated to mediterranean diet adherence and specific dietary intakes on general adult population
Yu et al. Long-term diet quality is associated with gut microbiome diversity and composition among urban Chinese adults
Holscher Dietary fiber and prebiotics and the gastrointestinal microbiota
Healey et al. Interindividual variability in gut microbiota and host response to dietary interventions
Browne et al. Human milk microbiome and maternal postnatal psychosocial distress
Sanders et al. Probiotics and prebiotics: prospects for public health and nutritional recommendations
Shen et al. High-level dietary fibre up-regulates colonic fermentation and relative abundance of saccharolytic bacteria within the human faecal microbiota in vitro
Ramnani et al. A randomised, double-blind, cross-over study investigating the prebiotic effect of agave fructans in healthy human subjects
Hemalatha et al. Effect of probiotic supplementation on total lactobacilli, bifidobacteria and short chain fatty acids in 2–5-year-old children
Barber et al. Metabolic response of intestinal microbiota to guar gum consumption
Chen et al. Effect of arabinogalactan on the gut microbiome: A randomized, double-blind, placebo-controlled, crossover trial in healthy adults
Majid et al. Faecal microbiota and short‐chain fatty acids in patients receiving enteral nutrition with standard or fructo‐oligosaccharides and fibre‐enriched formulas
Wernimont et al. Effect of an α-lactalbumin-enriched infant formula supplemented with oligofructose on fecal microbiota, stool characteristics, and hydration status: A randomized, double-blind, controlled trial
Jaagura et al. Low‐carbohydrate high‐fat weight reduction diet induces changes in human gut microbiota
Nybacka et al. A low FODMAP diet plus traditional dietary advice versus a low-carbohydrate diet versus pharmacological treatment in irritable bowel syndrome (CARIBS): a single-centre, single-blind, randomised controlled trial
Creedon et al. The impact of almonds and almond processing on gastrointestinal physiology, luminal microbiology, and gastrointestinal symptoms: a randomized controlled trial and mastication study
Mysonhimer et al. Prebiotic consumption alters microbiota but not biological markers of stress and inflammation or mental health symptoms in healthy adults: A randomized, controlled, crossover trial
Haddad et al. The infant gut microbiota at 12​ months of age is associated with human milk exposure but not with maternal pre-pregnancy body mass index or infant BMI-for-age z-scores
Yan et al. Does Fibre-fix provided to people with irritable bowel syndrome who are consuming a low FODMAP diet improve their gut health, gut microbiome, sleep and mental health? A double-blinded, randomised controlled trial
Alyousif et al. Gastrointestinal tolerance and microbiome response to snacks fortified with pea hull fiber: a randomized trial in older adults
Dahl et al. Resistant potato starches (type 4 RS) exhibit varying effects on laxation with and without phylum level changes in microbiota: A randomised trial in young adults